NRX Pharmaceuticals Inc (FRA:B1Q)
€ 4.86 0 (0%) Market Cap: 12.65 Mil Enterprise Value: 18.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

Q3 2022 NRX Pharmaceuticals Inc Earnings Call Transcript

Nov 14, 2022 / 01:00PM GMT
Release Date Price: €9.48 (+11.27%)
Operator

Good morning, and welcome to the NRx Pharmaceuticals Third Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode. (Operator Instructions) After today's presentation, there will be an opportunity to ask questions. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Suzanne Messere with Stern Investor Relations. Please, go ahead.

Suzanne Messere
Stern Investor Relations - Managing Director

Thank you, Andrea. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. Federal Securities Laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC.

The forward-looking statements made during this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot